Название: Обезвредить кислоту. Как нейтрализовать тайного врага вашего здоровья
Автор: Дэвид Перлмуттер
Издательство: Манн, Иванов и Фербер
Серия: МИФ Здоровый образ жизни
isbn: 9785001958116
isbn:
39
Kanbay M. et al. Uric Acid in Metabolic Syndrome: From an Innocent Bystander to a Central Player // European Journal of Internal Medicine. 2016. April. Vol. 29. Pp. 3–8 // doi.org/10.1016/j.ejim.2015.11.026.
40
Konta T. et al. Association Between Serum Uric Acid Levels and Mortality: A Nationwide Community-Based Cohort Study // Scientific Reports. 2020. April. Vol. 10. № 1. P. 6066 // doi.org/10.1038/s41598-020-63134-0.
41
Chen J.-H. et al. Serum Uric Acid Level as an Independent Risk Factor for All-Cause, Cardiovascular, and Ischemic Stroke Mortality: A Chinese Cohort Study // Arthritis & Rheumatology. 2009. February. Vol. 61. № 2. Pp. 225–232 // doi.org/10.1002/art.24164.
42
Zhao Y.-C. et al. Nonalcoholic Fatty Liver Disease: An Emerging Driver of Hypertension // Hypertension. 2020. February. Vol. 75. № 2. Pp. 275–284 // doi.org/10.1161/HYPERTENSIONAHA.119.13419. См. также Kasper P. et al. NAFLD and Cardiovascular Diseases: A Clinical Review // Clinical Research in Cardiology. 2021. July. Vol. 110. № 7. Pp. 921–937 // doi.org/10.1007/s00392-020-01709-7.
43
Younossi Z. M. Non-alcoholic Fatty Liver Disease – A Global Public Health Perspective // Journal of Hepatology. 2019. March. Vol. 70. № 3. Pp. 531–544 // doi.org/10.1016/j.jhep.2018.10.033.
44
Darmawan G., Hamijoyo L., Hasan I. Association Between Serum Uric Acid and Non-alcoholic Fatty Liver Disease: A Meta-Analysis // Acta Medica Indonesiana. 2017. April. Vol. 49. № 2. Pp. 136–147. См. также Margariti E. et al. Non-alcoholic Fatty Liver Disease May Develop in Individuals with Normal Body Mass Index // Annals of Gastroenterology. 2012. Vol. 25. № 1. Pp. 45–51; Oral A. et al. Relationship Between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-obese Patients // Medicina. 2019. September. Vol. 55. № 9. P. 600 // doi.org/10.3390/medicina55090600.
45
Paschos P. et al. Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease? // Current Vascular Pharmacology. 2018. Vol. 16. № 3. Pp. 269–275 // doi.org/10.2174/1570161115666170621082237.
46
Spiga R. et al. Uric Acid Is Associated with Inflammatory Biomarkers and Induces Inflammation via Activating the NF-κB Signaling Pathway in HepG2 Cells // Arteriosclerosis, Thrombosis, and Vascular Biology. 2017. June. Vol. 37. № 6. Pp. 1241–1249 // doi.org/10.1161/ATVBAHA.117.309128. См. также Tanaka T. et al. A Double Blind Placebo Controlled Randomized Trial of the Effect of Acute Uric Acid Changes on Inflammatory Markers in Humans: A Pilot Study // PLOS ONE. 2017. August. Vol. 12. № 8. P. e0181100 // doi.org/10.1371/journal.pone.0181100; Ruggiero C. et al. Uric Acid and Inflammatory Markers // European Heart Journal. 2006. May. Vol. 27. № 10. Pp. 1174–1181 // doi.org/10.1093/eurheartj/ehi879.
47
Gorman Ch., Park A., Dell K. Health: The Fires Within // Time. 2004. February 23. Vol. 163. № 8.
48
Gorman, Park, Dell. Health.
49
Gorman, Park, Dell. Health.
50
См. запись моего подкаста с доктором Людвигом от 3 января 2016 г. на Drperlmutter.com. Больше о докторе Людвиге и его работе см. Drdavidludwig.com.